Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given

Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.
No abstract available

Keywords: Arrythmias; Chloroquine; Novel Corona virus.

Publication types

  • Letter

MeSH terms

  • Antimalarials / adverse effects
  • Antimalarials / therapeutic use
  • Arrhythmias, Cardiac / chemically induced*
  • Arrhythmias, Cardiac / epidemiology
  • Betacoronavirus*
  • COVID-19
  • Chloroquine / adverse effects*
  • Chloroquine / therapeutic use
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / virology
  • Global Health
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Hydroxychloroquine / therapeutic use
  • Incidence
  • Pandemics*
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / virology
  • Risk Factors
  • SARS-CoV-2

Substances

  • Antimalarials
  • Hydroxychloroquine
  • Chloroquine